Megaprosthetic Implants the Next Generation (MING) (MING)
Bone Neoplasm of Hip (Diagnosis)
About this trial
This is an interventional treatment trial for Bone Neoplasm of Hip (Diagnosis)
Eligibility Criteria
Inclusion Criteria:
- Bone cancer patients requiring primary or revision femoral segmental replacements (excluding infections) and non-cancer patients requiring revision femoral segment replacement for aseptic loosening (excluding infections)
- Male or female, aged 18-80 years
- Participants willing and able to give informed consent for participation in the study
Exclusion Criteria:
- Participants unwilling or unable to give informed consent for participation in the study
- Patients undergoing revision due to infection, identified by positive growth from joint aspiration OR elevated pre-operative inflammatory markers OR radiographical evidence of prosthetic joint infection
- Bone cancer patients presenting with pathological fractures requiring segmental femoral replacement
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
porous collar
porous collar with hydroxyapathite
Patients with neoplasm of femur bone who require segmental bone resection and replasement with a large prosthesis would receive an implant which collar (a circular part that comes into direct contact with the remaining bone) will be porous, to allow for bone ingrowth and stabilization of the implant.
Patients with neoplasm of femur bone who require segmental bone resection and replasement with a large prosthesis would receive an implant which collar (a circular part that comes into direct contact with the remaining bone) will be porous and covered with hydroxyapathite particles, to allow for bone ingrowth and stabilization of the implant.